GlassScriptPhysician profile
Simon I Angeli
NPI 1942228325
$32,287.74
in general payments reported to CMS, 2019-2025
8 companies · $21K in 2025
The $21K reported for 2025 was more than what 96% of Otology & Neurotology providers received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $3,000 · 2021: $629 · 2022: $270 · 2023: $209 · 2024: $6,448 · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $20K · Consulting Fee: $6,786 · Food and Beverage: $1,129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $20,109.59 |
| Consulting Fee | $6,786.00 |
| Food and Beverage | $1,129.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $16,960.17 | 2019-2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Medtronic, INC. | $8,427.20 | 2024-2025 | Nim-Response, Nim Vital |
| Advanced Bionics, LLC | $3,294.57 | 2019-2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Acadia Pharmaceuticals INC | $3,000.00 | 2020 | |
| Stryker Corporation | $444.99 | 2022-2025 | Scopis Ent, Audion Et Dilation System, Core |
| Med-El Corporation | $142.29 | 2019 | |
| Janssen Biotech, INC. | $18.52 | 2024 | Rybrevant |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Angeli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.